![logo](/logos/FIXX.webp)
Homology Medicines, Inc.
NASDAQ:FIXX
0.93 (USD) • At close March 25, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Homology Medicines, Inc. |
Symbool | FIXX |
Munteenheid | USD |
Prijs | 0.935 |
Beurswaarde | 3,018,745 |
Dividendpercentage | 0% |
52-weken bereik | 0.9 - 26.64 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Albert Seymour Ph.D. |
Website | https://www.homologymedicines.com |
An error occurred while fetching data.
Over Homology Medicines, Inc.
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)